Anterior craniofacial resection for squamous cell carcinoma ethmoid sinus involving anterior skull base

2021 ◽  
Vol 5 (1) ◽  
pp. 38
Author(s):  
Saurabh Varshney ◽  
Sumeet Angral ◽  
RajnishKumar Arora ◽  
Manu Malhotra ◽  
AmitKumar Tyagi ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Skull Base ◽  
Squamous Cell ◽  
Ethmoid Sinus ◽  
Anterior Skull Base ◽  
Craniofacial Resection

scholarly journals Treatment Outcomes of Locally Advanced Squamous Cell Carcinoma of the Ethmoid Sinus Treated with Anterior Craniofacial Resection or Chemoradiotherapy

2017 ◽  
Vol 10 (1) ◽  
pp. 339-349
Author(s):  
Takeharu Ono ◽  
Norimitsu Tanaka ◽  
Hirohito Umeno ◽  
Kiyohiko Sakata ◽  
Motohiro Morioka ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Locally Advanced ◽  
Ethmoid Sinus ◽  
Surgical Margins ◽  
Advanced Squamous Cell Carcinoma ◽  
Craniofacial Resection ◽  
Positive Surgical Margins ◽  
Safety Margins

We retrospectively analyzed 14 patients with locally advanced squamous cell carcinoma of ethmoid sinus (LASCC-ES) for the feasibility of anterior craniofacial resection (ACFR). Ethmoid cancer treatment comprised alternating chemoradiotherapy (ALCRT; n = 1), concomitant radiotherapy and intra-arterial cisplatin (RADPLAT; n = 4) and ACFR (n = 9). The 3- and 5-year overall survival (OS) rates of patients were 47.6 and 39.6%, respectively. The 3-year local control (LC) rates of chemoradiotherapy (CRT; ALCRT and RADPLAT) (n = 5) and ACFR (n = 9) groups were 0 and 66.7% (p = 0.012), respectively. The 3-year progression-free survival (PFS) rate of the CRT and ACFR groups were 0 and 55.6% (p = 0.018), respectively. The 3-year OS rate of the CRT and ACFR groups were 0 and 76.2% (p = 0.005), respectively. Postoperative pathological examinations confirmed positive margins in 3 (33%) of 9 cases. The 3-year LC and PFS rates of cases (n = 3) with positive surgical margins were significantly poorer than those of cases (n = 6) with negative surgical margins. Although ACFR for LASCC-ES is a feasible treatment, cases with positive surgical margins were more prone to local relapse. Therefore, surgical safety margins should be thoroughly assessed.

Endonasal endoscopic surgery for squamous cell carcinoma of the sinonasal cavities and skull base: Oncologic outcomes based on treatment strategy and tumor etiology

Head & Neck ◽  
2014 ◽  
Vol 37 (8) ◽  
pp. 1163-1169 ◽  
Author(s):  
John R. de Almeida ◽  
Shirley Y. Su ◽  
Maria Koutourousiou ◽  
Francisco Vaz Guimaraes Filho ◽  
Juan C. Fernandez Miranda ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Skull Base ◽  
Squamous Cell ◽  
Endoscopic Surgery ◽  
Treatment Strategy ◽  
Oncologic Outcomes ◽  
Endonasal Endoscopic Surgery

scholarly journals Management for squamous cell carcinoma of the nasal cavity and ethmoid sinus: A single institution experience

2015 ◽  
Vol 42 (5) ◽  
pp. 377-381 ◽  
Author(s):  
Akihiro Homma ◽  
Yuji Nakamaru ◽  
Tomohiro Sakashita ◽  
Rikiya Onimaru ◽  
Shunsuke Terasaka ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Nasal Cavity ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Ethmoid Sinus ◽  
Single Institution

scholarly journals Leptomeningeal Carcinomatosis from Squamous Cell Carcinoma of the Ethmoid Sinus: A Case Report

Cureus ◽  
2019 ◽  
Author(s):  
Samer G Zammar ◽  
Max Hennessy ◽  
Joshua Warrick ◽  
Neerav Goyal ◽  
Brad E Zacharia
Keyword(s):  
Squamous Cell Carcinoma ◽  
Case Report ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
Leptomeningeal Carcinomatosis ◽  
Ethmoid Sinus
Sign in / Sign up

Export Citation Format

Share Document